Although the glycemic control was significantly different among the three groups, there were no significant differences in gender, T2DM duration, anti-hyperglycemic therapy, high-density lipoprotein cholesterol (HDL-C), alanine aminotransferase, systolic blood pressure (SBP), smoking habits, and the prevalence of hypertension, stroke, and dyslipidemia at baseline. The gene discussed is GPT; the disease is stroke disorder.